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Abstract
Previous studies have found an association between chronic kidney disease and poor outcomes in stroke patients. However, 
there is a paucity of literature evaluating this association by stroke type. We therefore aimed to explore the association 
between CKD and stroke outcomes according to type of stroke. The data consisting of 594,681 stroke patients were acquired 
from Universal Coverage Health Security Insurance Scheme Database in Thailand. Binary logistic regression was used to 
assess the relationship of CKD and outcomes, which were as follows; in-hospital mortality, long length of stay (>3 days), 
pneumonia, sepsis, respiratory failure and myocardial infarction. Results: after fully adjusting for covariates, CKD was asso-
ciated with increased odds of in-hospital mortality in patients with ischemic (OR 1.32; 95% CI = 1.27–1.38), haemorrhagic 
(OR 1.31; 95% CI = 1.24–1.39), and other undetermined stroke type (OR 1.44; 95% CI = 1.21–1.73). CKD was found to 
be associated with increased odds of pneumonia, sepsis, respiratory failure and myocardial infarction in ischaemic stroke. 
While CKD was found to be associated with increase odds of sepsis, respiratory failure, and myocardial infarction, decrease 
odds of pneumonia was observed in patients with haemorrhagic stroke. In other undetermined stroke type, CKD was found 
to only be associated with increase odds of sepsis and respiratory failure, while there is no significant association of CKD 
and increase or decrease odds with pneumonia and myocardial infarction. CKD was associated with poor outcomes in all 
stroke types. CKD should be considered as part of stroke prognosis as well as identifying at risk patient population for in-
hospital complications.
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Introduction
Previous studies have demonstrated a high prevalence of 
chronic kidney disease (CKD) in patients with acute stroke, 
36% when using modification of diet in renal disease for-
mula, and 18% when using the Mayo Clinic Equation [1]. 
Furthermore, CKD has been associated with a twofold 
increased risk of in-hospital mortality [2]. However, the 
impact of CKD on outcomes on specific sub-types of acute 
stroke (ischaemic and haemorrhagic) remains uncertain. 
Given the pathophysiological differences between differ-
ent stroke types, a detailed assessment of the association 
between CKD and stroke outcomes and complications is 
warranted. This may be helpful in evaluating the prognosis 
of patients admitted with stroke, thereby assisting clinicians 
in making informed decisions in the clinical care of stroke 
patients.
To date, a handful of studies assessing the association 
between CKD and stroke have presented findings according 
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to stroke sub-types. However, the findings within these stud-
ies have not been consistent. For instance, Luo et al. reported 
a higher risk of death due to CKD in ischemic stroke patients 
compared to haemorrhagic stroke [3], while Snarska et al. 
reported higher risk in haemorrhagic stroke [4]. The aim 
of the current study is therefore to evaluate the association 
between CKD and stroke outcomes by stroke type. The 
outcomes under assessment include in-hospital mortality, 
increased length of hospital stay, pneumonia, sepsis, respira-
tory failure and myocardial infarction.
Materials and methods
Data collection
The dataset was acquired from Universal Coverage Health 
Security Insurance Scheme Database in Thailand. The Thai 
population is covered by three insurance schemes. The civil 
servant benefit system covers government employees and 
their dependents (~7% of the population) and the social 
security scheme that covers private sector employees (~13% 
of the population). The remaining 80% is covered by the 
universal coverage health security scheme. The current study 
consisted of 594,681 participants with acute stroke. Data 
were acquired from reimbursement forms using ICD codes. 
The data covers in-hospital patients from November 2005 
up to January 2015.
Stroke diagnosis was made based on clinical features 
and investigations including brain imaging. Incident stroke 
was then identified with ICD coding from I61–I6400 and 
categorized into ischemic stroke (I63), haemorrhagic stroke 
(I61, I62) or other undetermined stroke type (I64). Patients 
with CKD were identified using ICD codes N18.1–N18.9, 
representing CKD stages 1–5, end-stage renal failure and 
unspecified CKD. All patients are either classified as having 
CKD or not having CKD, as due to the nature of data collec-
tion for the Universal Coverage Health Security Insurance 
Scheme Database, there is no distinctions made between the 
different stages of CKD. In addition, ICD code I12 (hyper-
tensive kidney disease) was included. Outcomes of this 
study included in-hospital mortality, long length of stay and 
complications, including pneumonia (J14, J15, J18, J69), 
sepsis (A40, A41), respiratory failure (J96) and myocardial 
infarction (I21). Long length of stay was defined as a length 
of stay longer than the median (3 days). Twelve co-mor-
bidities were selected including anaemia (D50, D53, D56, 
D58, D59), chronic ischemic heart disease (I25), arrhyth-
mias (I48, I49), hypertension (I10), heart failure (I50), type 
2 diabetic mellitus (E11), chronic obstructive pulmonary 
disease (COPD) (J44), dyslipidaemia (E78), alcohol related 
disease (F10), age related physical disability (R54), previous 
stroke (G81, I63) and other degenerative disease of nervous 
system (G31).
Characteristics of the study population were presented 
according to CKD status for overall population as well as 
by stroke type. The Chi-squared test and independent T test 
were used to compare the descriptive statistics of those with 
and without CKD. Using binary logistic regression, odds 
ratios were calculated for the association of CKD with vari-
ous complications for the overall population and by three dif-
ferent stroke types. A total of four models were constructed 
to assess these associations. An unadjusted model; model 
A adjusting for age and sex; model B adjusting for model 
A plus the 12 co-morbidities mentioned above; model C 
adjusted for model B+ stroke type. The value of odds ratio is 
considered statically significant difference if the odds ratios’ 
confidence intervals cross 1.0. p values were also given to 
show statistical significance.
Results
The current study included 594,681 stroke patients and 
18,994 (3.2%) had CKD. Ischaemic stroke was the most 
common stroke type (51.5%), followed by haemorrhagic 
stroke (32.9%) with the remainder being made up of unde-
termined stroke types. The majority of patients in the study 
were elderly with a mean age ± SD of 63.75 ± 14.52. Within 
the entire sample population, 70,056 (11.8%) patients died 
within the hospital. Table 1 depicts the baseline charac-
teristics of study participants. Patients with CKD had a 
significantly higher mean age compared to those without 
CKD. CKD patients were also more likely to experience an 
ischaemic stroke. Furthermore, CKD status was significantly 
associated with an increased likelihood of co-morbidities 
including; ischemic heart disease, arrhythmia, heart failure, 
hypertension, type 2 diabetic mellitus, anaemia, chronic 
obstructive pulmonary disease, dyslipidaemia and other 
degenerative disease of the nervous system. Conversely, 
there was a significantly higher prevalence of previous 
strokes, age related physical disability and alcohol related 
disease in those without CKD.
Table 2 displays the baseline characteristics of partici-
pants by stroke type. Overall, the patterns observed are 
largely consistent with those in Table 1. However, there 
were a handful of exceptions to this trend. Among patients 
who suffered from a haemorrhagic stroke, there was no 
statistically significant difference in the incidence of pre-
vious strokes regardless of whether the patient had CKD 
or not. Likewise, when comparing patients with or with-
out CKD among those who suffered from an undetermined 
stroke, there was no significant difference in the prevalence 
of arrhythmias and other disease of the nervous system. 
Regardless of stroke type, there was no significant difference 
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in age related physical disability when comparing those with 
or without CKD.
Table 3 depicts odds ratios quantifying the association 
between CKD and in-hospital mortality and long length of 
stay in different stroke types. After adjusting for confound-
ers, CKD was found to be associated with an increased 
odds ratio of mortality in ischemic, haemorrhagic and 
other undetermined stroke types. Increased length of stay 
was only associated with ischemic and other undetermined 
stroke types, while haemorrhagic stroke is associated with 
a decreased length of stay. Table 4 depicts the odds ratio 
quantifying the association between CKD and post stroke 
complications, including pneumonia, sepsis, respiratory 
failure, myocardial infarction. CKD was found to be associ-
ated with increased odds of pneumonia, sepsis, respiratory 
failure and myocardial infarction in ischaemic stroke. While 
CKD was found to be associated with increase odds of sep-
sis, respiratory failure, and myocardial infarction, decrease 
odds of pneumonia was observed in patients with haemor-
rhagic stroke. In other undetermined stroke type, CKD was 
found to only be associated with increase odds of sepsis and 
respiratory failure, while there is no significant association 
of CKD and increase or decrease odds with pneumonia and 
myocardial infarction.
Discussion
Our study demonstrated that CKD is associated with a 
significantly increased odds of in-hospital mortality, sep-
sis, respiratory failure and myocardial infarction even after 
adjusting for age, sex, stroke type and co-morbidities. When 
comparing ischemic stroke with haemorrhagic stroke, no 
significant difference in odds ratio for in-hospital mortal-
ity subsequent to adjustment for confounders. Similarly, 
undetermined stroke type did not demonstrate significantly 
increased odds of poor outcome after adjustment.
Our study also contained 15.7% of stroke that are classed 
as undermined type due to negative CT findings in the pres-
ence of clinically diagnosed stroke syndrome. In the absence 
of clear haemorrhage in the imaging, they are indeed ischae-
mic stroke and this is evident by the fact that the outcomes in 
this group is similar to CT/MRI confirmed ischemic stroke 
sub-type.
Table 1  Baseline characteristics of sample population
All stroke type
Total (n = 594,681) Without CKD 
(n = 575,687)
With CKD (n = 18,994) p value
Mean age ± standard deviation 63.75 ± 14.52 63.62 ± 14.56 67.59 ± 12.59 < 0.001
Sex 0.007
 Male 55.0 (327,167) 55.0 (316,899) 54.1 (10,268)
 Female 45.0 (267,514) 45.0 (258,788) 45.9 (8,726)
Stroke type < 0.001
 Ischemic 51.5 (306,154) 51.2 (294,636) 60.6 (11,518)
 Hemorrhagic 32.9 (195,392) 33.1 (190,509) 25.7 (4.883)
 Other 15.7 (93,135) 15.7 (90,542) 13.7 (2,593)
Co-morbidities
 Chronic ischemic heart disease 2.7 (16,167) 2.6 (14,867) 6.8 (1,300) < 0.001
 Arrhythmia 6.6 (39,115) 6.5 (37,569) 8.1 (1,546) < 0.001
 Heart failure 1.5 (8,855) 1.4 (8,063) 4.2 (792)  < 0.001
 Hypertension 44.6 (265,189) 43.9 (252,739) 65.5 (12,450) < 0.001
 Type 2 diabetic mellitus 16.7 (99,367) 15.9 (91,428) 41.8 (7,939) < 0.001
 Anemia 5.4 (32,043) 4.8 (27,519) 23.8 (4,524) < 0.001
 Chronic obstructive pulmonary Disease 1.9 (11,497) 1.9 (10,988) 2.7 (509) < 0.001
 Dyslipidaemia 19.8 (117,498) 19.6 (112,961) 23.9 (4,537) < 0.001
 Alcohol related disease 1.5 (9.216) 1.6 (9,129) 0.5 (87) < 0.001
 Age related physical disability 0.6 (3,497) 0.6 (3,409) 0.5 (88) 0.022
 Previous stroke 7.9 (46,957) 7.9 (45,642) 6.9 (1,315) < 0.001
 Other degenerative disease of nervous system 0.8 (4,941) 0.8 (4,689) 1.3 (252) < 0.001
Outcomes
 In-hospital mortality 11.8 (70,056) 11.7 (67,095) 15.6 (2961) < 0.001
 Long length of stay 46.6 (277,258) 46.4 (267,316) 52.3 (9942) < 0.001
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Our findings were comparable to those in previously 
published literature. For example, Ovbiagele et al. demon-
strated that CKD was associated with an increased risk of in-
hospital mortality [5]. However, Ovbiagele and colleagues 
observed a significantly increased risk is seen for ischemic 
stroke compared to haemorrhagic stroke after adjusting for 
risk factors using the Charlson Comorbidity index, whereas 
we did not. One possible reason for this discrepancy is that 
our model included anaemia, which has been shown to be an 
independent prognostic indicator for outcome of stroke [6, 
7] but was not adjusted for in this study. Furthermore, previ-
ous literature has established anaemia as a poor prognostic 
indicator in patients with CKD as well [8]. The decrease in 
odds ratio after adjusting for anaemia may indicate that one 
of the major causes of poor outcome due to CKD may be 
partially due to CKD induced anaemia [9].
A previous study has shown that risk of infection, sepsis, 
and risk of poor outcomes due to infection, are increased 
in those with CKD [10, 11]. For example, a previous study 
has shown that 60% of patients who acquired sepsis after 
stroke died [12]. Our study shows that there is an increased 
risk of sepsis; however, in the case of haemorrhagic stroke, 
CKD patients appears to be protective against pneumonia. 
In patient with ischaemic stroke, it is associated with only a 
slight increase odds ratio for pneumonia. While CKD may 
be a risk factor to community acquired and hospital acquired 
pneumonia, it is not a risk factor to aspiration pneumonia. 
Community acquired and hospital acquired pneumonia, and 
aspiration pneumonia occurs as a complication of stroke 
[13–15], with up to a third of patients suffering from stroke 
suffers from pneumonia [10], regardless of CKD status. As 
seen in our study, increased risk of pneumonia is only appar-
ent in ischaemic stroke, mostly likely due to an immune-
depression response in patients caused by ischaemic stroke 
[11], making patients more vulnerable to infections. In the 
case of haemorrhagic stroke, it could be due to competing 
risk, where patients passed away due to other causes before 
the development of pneumonia was possible. Our study also 
shows a 51% increase in the odds of developing respira-
tory failure. Studies have shown an increase risk of venous 
thromboembolism and pulmonary embolism with patients 
who have CKD [16, 17], or with patients who had a stroke, 
which may lead to respiratory failure. Patients with pulmo-
nary embolism can also be a cause for in-hospital mortality 
[18]. Finally, CKD is also known risk factor to cardiovascu-
lar complications [19, 20]. Our study found an association 
between CKD and development of a myocardial infarction, 
with a 65% increase in the odds. Cardiovascular diseases are 
Table 2  Baseline characteristics of sample population by stroke type
Entries marked with */**/*** shows the level of statistical significance
Entries that are not marked are not statistically significant and have a p value >0.05
*p  <  0.05, **p  < 0.01, ***p < 0.001
Ischemic stroke Haemorrhagic stroke Other stroke types
Without CKD With CKD Without CKD With CKD Without CKD With CKD
Mean age ± standard deviation 65.16 ± 13.75 69.15 ± 11.86*** 60.26 ± 15.59 63.09 ± 13.71*** 65.66 ± 13.64 69.13 ± 11.48***
Sex (male) 52.7 (155,385) 53.7 (6,188)* 60.1 (114,453) 56.7 (2,767)*** 52.0 (47,061) 50.6 (1,313)
Co-morbidities
 Chronic ischemic Heart Disease 3.4 (10,156) 7.9 (908)*** 1.2 (2,331) 5.0 (245)*** 2.6 (2,380) 5.7 (147)***
 Arrhythmia 9.6 (28,196) 10.3 (1,185)** 2.2 (4,116) 4.2 (207)*** 5.8 (5,257) 5.9 (154)
 Heart failure 1.8 (5,430) 4.5 (518)*** 0.7 (1,425) 3.4 (167)*** 4.1 (107) 4.1 (107)***
 Hypertension 44.2 (130,355) 64.8 (7,468)*** 46.4 (88,395) 70.2 (3,430)*** 37.5 (33,989) 59.9 (1,552)***
 Type 2 diabetic mellitus 20.3 (59,726) 44.4 (5,117)*** 8.8 (16,702) 35.0 (1,707)*** 16.6 (15,000) 43.0 (1,115)***
 Anemia 5.4 (15,932) 24.8 (2,854)*** 4.5 (8,511) 23.9 (1,167)*** 3.4 (3,076) 19.4 (503)***
 Chronic obstructive Pulmonary 
disease
2.2 (6,614) 2.9 (330)*** 1.3 (2,543) 2.3 (111)*** 2.0 (1,831) 2.6 (68)*
 Dyslipidaemia 28.9 (85,259) 30.5 (3,509)*** 7.3 (13,883) 11.7 (572)*** 15.3 (13,819) 17.6 (456)**
 Alcohol related disease 1.1 (3,321) 0.4 (50)*** 2.6 (5,016) 0.7 (36)*** 0.9 (792) 0.0 (1)***
 Age related physical disability 0.5 (1,592) 0.5 (52) 0.4 (734) 0.3 (14) 1.2 (1,083) 0.8 (22)
 Previous stroke 8.9 (26,260) 7.3 (844)*** 6.7 (12,804) 6.3 (309) 7.3 (6,578) 6.2 (162)*
 Other degenerative disease of nerv-
ous system
1.3 (3,702) 1.8 (213)*** 0.3 (570) 0.5 (26)** 0.5 (417) 0.5 (13)
Outcomes
 In-hospital mortality 6.8 (20,039) 11.3 (1304)*** 23.2 (44,106) 30.9 (1511)*** 3.3 (2950) 5.6 (2447)***
 Long length of stay 45.5 (134,160) 53.3 (6137)*** 54.2 (103,351) 56.7 (2768)** 32.9 (29,805) 40.0 (1037)***
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a major contributor to mortality to patients who survives a 
stroke, with up to two-thirds of post stroke mortality attrib-
uted to vascular diseases [21].
The current study has several limitations. Of note, the 
prevalence of CKD is low in our study compared to other 
studies in this area [1, 5], and this is likely to be due to 
underreporting of CKD. Hence, the results we observed 
are more likely to be relevant to moderate to severe CKD 
as opposed to milder forms of CKD which is prevalent in 
the general population. The data does not stratify CKD by 
eGFR, hence we were unable to determine the severity of 
CKD in individual patients and thus the study was unable to 
determine whether a decreasing eGFR will result in worsen-
ing outcomes. The data does not include date of diagnosis 
other co-morbid conditions. As such, some cases of respira-
tory failure and myocardial infarction could be a pre-stroke 
event instead of a complication. No data was available for 
stroke severity (e.g., NIHSS), hence we were not able to 
examine role of stroke severity in observed findings.
Despite these limitations, this study has several strengths. 
Our large sample size allowed stratification of stroke types 
and provided a robust assessment of association between 
each stroke types. Due to the nature of the data, we are able 
to base this study on a national sized population thereby 
minimising selection bias. We are also able to assess a range 
of outcomes including pneumonia, sepsis, respiratory failure 
and myocardial infarction as well In-hospital mortality and 
length of stay.
Table 3  Odds ratio with 95% confidence interval for the associa-
tion of CKD with in-hospital mortality and length of stay in stroke 
patients
a Variables adjusted: model A: age and sex, model B: model A + co-
morbidities, model C: model B + stroke type




p value Length of stay p value
All stroke  typesa
 Unadjusted 1.40 (1.35–1.46) < 0.001 1.27 (1.23–1.30) < 0.001
 Model A 1.40 (1.35–1.46) < 0.001 1.27 (1.23–1.31) < 0.001
 Model B 1.26 (1.21–1.31) < 0.001 1.03 (1.00–1.06) 0.100
 Model C 1.26 (1.21–1.32) < 0.001 1.03 (0.99–1.05) 0.174
Ischaemicb
 Unadjusted 1.75 (1.65–1.86) < 0.001 1.36 (1.31–1.42) < 0.001
 Model A 1.66 (1.56–1.76) < 0.001 1.35 (1.30–1.40) < 0.001
 Model B 1.32 (1.24–1.41) < 0.001 1.11 (1.07–1.15)   0.001
Haemorrhagicb
 Unadjusted 1.49 (1.40–1.58) < 0.001 1.10 (1.04–1.17) < 0.001
 Model A 1.47 (1.38–1.56) < 0.001 1.11 (1.04–1.17) 0.001
 Model B 1.31 (1.23–1.39) < 0.001 0.83 (0.79–0.88) < 0.001
Other  typesb
 Unadjusted 1.77 (1.49–2.10) < 0.001 1.36 (1.25–1.47) < 0.001
 Model A 1.68 (1.41–1.99) < 0.001 1.33 (1.22–1.44) < 0.001
 Model B 1.44 (1.21–1.72) < 0.001 1.13 (1.04–1.22) 0.005
Table 4  Odds ratio with 95% confidence interval for the association of CKD with post-stroke complications in stroke patients
a Variables adjusted: model A: age and sex, model B: model A + co-morbidity, model C: model B + stroke type
b Variables adjusted: model A: age and sex, model B: model A + co-morbidity
Pneumonia p value Sepsis p value Respiratory failure p value Myocardial infarction p value
All stroke  typesa
 Unadjusted 1.46 (1.40–1.52) < 0.001 2.20 (2.07–2.33) < 0.001 1.94 (1.85–2.02) < 0.001 2.56 (2.26–2.91) < 0.001
 Model A 1.36 (1.30–1.42) < 0.001 2.10 (1.98–2.23) < 0.001 1.90 (1.82–1.99) < 0.001 2.37 (2.09–2.69) < 0.001
 Model B 0.98 (0.93–1.02) 0.280 1.41 (1.32–1.50) < 0.001 1.51 (1.44–1.58) < 0.001 1.67 (1.46–1.90) < 0.001
 Model C 0.97 (0.93–1.02) 0.231 1.40 (1.32–1.49) < 0.001 1.51 (1.44–1.58) < 0.001 1.65 (1.45–1.89) < 0.001
Ischaemicb
 Unadjusted 1.60 (1.51–1.69) < 0.001 2.29 (2.13–2.46) < 0.001 2.07 (1.95–2.20) < 0.001 2.33 (2.00–2.70) < 0.001
 Model A 1.44 (1.36–1.52) < 0.001 2.16 (2.01–2.33) < 0.001 1.95 (1.83–2.07) < 0.001 2.17 (1.86–2.52) < 0.001
 Model B 1.08 (1.02–1.15) 0.009 1.54 (1.42–1.66) < 0.001 1.50 (1.41–1.60) < 0.001 1.62 (1.38–1.90) < 0.001
Haemorrhagicb
 Unadjusted 1.31 (1.21–1.42) < 0.001 1.98 (1.77–2.22) < 0.001 2.12 (1.98–2.27) < 0.001 3.04 (2.32–3.99) < 0.001
 Model A 1.27 (1.17–1.37) < 0.001 1.93 (1.72–2.16) < 0.001 2.09 (1.95–2.24) < 0.001 2.87 (2.19–3.76) < 0.001
 Model B 0.79 (0.72–0.86) < 0.001 1.14 (1.01–1.28) 0.037 1.65 (1.53–1.77) < 0.001 1.82 (1.36–2.43) < 0.001
Other  typesb
 Unadjusted 1.47 (1.27–1.71) < 0.001 2.20 (1.77–2.72) < 0.001 2.27 (1.87–2.75) < 0.001 2.07 (1.32–3.26) 0.002
 Model A 1.34 (1.16–1.56) < 0.001 2.07 (1.67–2.56) < 0.001 2.15 (1.77–2.60) < 0.001 1.96 (1.24–3.08) 0.004
 Model B 1.13 (0.97–1.31) 0.126 1.57 (1.25–1.96) < 0.001 1.60 (1.30–1.95) < 0.001 1.40 (0.87–2.24) 0.167
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To conclude, the presence of CKD can worsen the prog-
nosis of a patient who suffered from a stroke, regardless of 
the type of stroke. As such, patients may benefit from taking 
CKD and renal dysfunction into account when prognosticat-
ing. Finally, better management of CKD may improve out-
comes in patients with stroke. Future studies assessing the 
association between CKD and stroke outcomes may benefit 
from evaluating the impact interventions targeted at CKD on 
improving stroke outcomes.
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